Navigation Links
Dehaier Strengthens Intellectual Property Portfolio
Date:6/27/2011

BEIJING, June 27, 2011 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it was granted three new patents by State Intellectual Property Office of the People's Republic of China ("SIPO"). The patent awards were related to the design of Dehaier's Sleep Diagnostic and Continuous Positive Airway Pressure ("CPAP") homecare medical products and Medical-grade Air Compressor. These patents were issued in June 2011 and are valid for 10 years.

(Logo: http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO)

Design patents are granted to products that incorporate unique shapes, patterns, colors or combinations of features that strengthen a product's brand value upon commercialization. According to Patent Law of People's Republic of China, design patents are protected and defensible under national Intellectual Property Law.

"Innovation through continued R&D is key to supporting growth in our self-branded homecare business, and we believe these patent awards further protect our ability to provide the market with proprietary best-in-breed products. Developing new designs and enriching self-branded product offerings in the homecare segment is one of our key growth strategies to meet diversified market needs with portable, personalized and differential products," said Mr. Ping Chen, CEO of Dehaier, "These new patents bring our total intellectual property holdings to five patents and five software copyrights, in addition to other proprietary technology, such as trade secrets. Additionally, we currently have three pending patents and six pending software copyrights applications with SIPO for homecare products. We will continue to strengthen our R&D capabilities and plan to continue to build our intellectual property portfolio to increase our brand recognition, gain market share and continue growing our business. "

About Dehaier Medical Systems Ltd.Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products in China, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), Welch Allyn (USA), HEYER (Germany), Timesco (UK), eVent Medical (US) and JMS (Japan). Dehaier's technology is based on five patents and five software copyrights; additionally we have three pending patents and six pending software copyrights, and proprietary technology. More information may be found at http://www.chinadhr.com.

Forward-looking StatementsThis news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, future developments in payment for and demand for medical equipment and services, implementation of and performance under the joint venture agreement by all parties, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.Contact UsIn the US:The Piacente Group, Inc.Investor RelationsBrandi Floberg or Lee RothPhone: +1-212-481-2050Email: dehaier@tpg-ir.com In China:The Piacente Group, Inc.Investor RelationsWendy SunPhone: +86-10-6590-7991Email: dehaier@tpg-ir.com Dehaier Medical Systems LimitedRita LiuCFOPhone: +86-10-8844-5026Email: liuz@dehaier.com.cn
'/>"/>

SOURCE Dehaier Medical Systems Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dehaier Medical Systems Announces Closing of Initial Public Offering on NASDAQ
2. Dehaier Medical Systems Announces First Quarter Net Income Up 54%
3. Dehaier Medical Systems Announces New Exclusive China Distribution Agreement with Welch Allyn, Further Broadening Companys Product Lines
4. Dehaier Medical Systems Chief Executive Officer To Ring NASDAQ Stock Market Closing Bell
5. Dehaier Medical Systems to Present to Investors at Global Hunter Securities 2010 China Investor Conference in San Francisco
6. Dehaier Medical Systems Acquires Emergency Ventilator Series to Extend Product Line
7. Dehaier Medical Systems Q2 Revenue Up 46% to $4.83 Million; Net Income Up 59% to 1.14 Million; EPS 0.27
8. Dehaier Medical Systems Announces Engagement of RedChip Companies to Lead Public and Investor Relations
9. Dehaier Medical Shows New Products at 2010 China International Medical Equipment Fair
10. Dehaier Medical Wins $2 Million Distribution Bid for Rural Healthcare Construction Project
11. Dehaier Medical to Participate in MEDICA International Trade Fair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... 2017 Stock-Callers.com today evaluates the following ... ), Novo Nordisk A/S (NYSE: NVO ), Sucampo ... Holdings Inc. (NASDAQ: PTX ). These stocks belong ... th , 2017, finishing near its session lows. As per ... 0.7%, while shares of health care companies in the S&P ...
(Date:1/20/2017)... LONDON , January 20, 2017 Avillion ... the appointment of Mark Weinberg , MD MBA as Chief ... , USA . ... Dr Weinberg has spent more than 17 ... "top 20" pharma companies to micro-cap biotech. Over the course of ...
(Date:1/19/2017)... 19, 2017 The U.S. Food and Drug Administration ... Constipation (CIC) in adult patients. "No one ... said Julie Beitz , M.D., director of the Office ... Evaluation and Research. "With the availability of new therapies, patients ... their condition." ...
Breaking Medicine Technology:
(Date:1/20/2017)... Boca Raton, FL (PRWEB) , ... January 20, 2017 , ... ... supplement development, announced it attended the January ECRM trade show to continue the marketing ... technologically advanced vitamin C supplement, known for providing 400 percent better absorption than traditional ...
(Date:1/20/2017)... ... 2017 , ... Michael and Betsy Brauser celebrated 5 years of Betsy’s participation ... trial has been life-saving as she has been on the trial for more ... diagnosed with ovarian cancer in 2009. She underwent standard chemotherapy but a year later ...
(Date:1/20/2017)... ... ... “Code Word: Chocolate Biscuit”: a biographical account following a man who went on to support ... author, Marlyn Ivey, born in Lynn Haven, Florida and at the age of 5, his ... of age, he joined the Navy and got married right out of boot camp. ...
(Date:1/20/2017)... ... ... “Knowledge is God’s Lighthouse”: a moving and colorful collection of prayers that ... of published author, Gene Gaapf, a retired truck driver, and a long-time writer, whose ... since high school and have many different titles,” Gaapf mentions about his different works. ...
(Date:1/19/2017)... ... January 19, 2017 , ... Next week after January 20th, the fear for ... games that circumvent health needs of over 30 million. Many interviews with Dr. Carol ... needs government public servants were suppose to prioritize. Interviews provided below. , ...
Breaking Medicine News(10 mins):